Magnetic resonance spectroscopy studies of the glutamatergic system in mood disorders: a pathway to diagnosis, novel therapeutics, and personalized medicine?
Salvadore
Giacomo
G
Experimental Therapeutics and Pathophysiology Branch, Division of Intramural Research Programs, National Institute of Mental Health, National Institutes of Health, Department of Health and HumanServices, Bethesda, Maryland 20892, USA.
Zarate
Carlos A
CA
D015415:Biomarkers / Q000378:metabolism; D016503:Drug Delivery Systems / Q000379:methods*; D018698:Glutamic Acid / Q000378:metabolism*; D006801:Humans; D009682:Magnetic Resonance Spectroscopy / Q000379:methods*; D008959:Models, Neurological; D019964:Mood Disorders / Q000175:diagnosis* / Q000188:drug therapy*; D057285:Precision Medicine / Q000379:methods*
D015415:Biomarkers; D018698:Glutamic Acid